Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 2
2000 2
2003 1
2004 1
2005 4
2006 1
2007 1
2008 1
2009 1
2010 3
2011 1
2012 2
2013 1
2014 1
2015 3
2016 1
2018 1
2020 2
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Strategies for multivessel revascularization in patients with diabetes.
Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators. Farkouh ME, et al. N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4. N Engl J Med. 2012. PMID: 23121323 Free article. Clinical Trial.
APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators. Parsa A, et al. N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9. N Engl J Med. 2013. PMID: 24206458 Free PMC article.
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators. Sawhney JP, et al. Indian Heart J. 2018 Nov-Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12. Indian Heart J. 2018. PMID: 30580852 Free PMC article. Clinical Trial.
Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial.
Bonati LH, Dobson J, Featherstone RL, Ederle J, van der Worp HB, de Borst GJ, Mali WP, Beard JD, Cleveland T, Engelter ST, Lyrer PA, Ford GA, Dorman PJ, Brown MM; International Carotid Stenting Study investigators. Bonati LH, et al. Lancet. 2015 Feb 7;385(9967):529-38. doi: 10.1016/S0140-6736(14)61184-3. Epub 2014 Oct 14. Lancet. 2015. PMID: 25453443 Free PMC article. Clinical Trial.
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial.
International Carotid Stenting Study investigators, Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, Lo TH, Gaines P, Dorman PJ, Macdonald S, Lyrer PA, Hendriks JM, McCollum C, Nederkoorn PJ, Brown MM. International Carotid Stenting Study investigators, et al. Lancet. 2010 Mar 20;375(9719):985-97. doi: 10.1016/S0140-6736(10)60239-5. Epub 2010 Feb 25. Lancet. 2010. PMID: 20189239 Free PMC article. Clinical Trial.
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G; BEST3 Trial team, Sasieni P. Fitzgerald RC, et al. Lancet. 2020 Aug 1;396(10247):333-344. doi: 10.1016/S0140-6736(20)31099-0. Lancet. 2020. PMID: 32738955 Free PMC article. Clinical Trial.
BACKGROUND: Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is unclear. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett's oesoph …
BACKGROUND: Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; however, the optimal diagnostic stra …
Roy Adaptation Model: ICU application.
Giger JA, Bower CA, Miller SW. Giger JA, et al. Dimens Crit Care Nurs. 1987 Jul-Aug;6(4):215-24. doi: 10.1097/00003465-198707000-00004. Dimens Crit Care Nurs. 1987. PMID: 3650144 No abstract available.
Gravitational Test beyond the First Post-Newtonian Order with the Shadow of the M87 Black Hole.
Psaltis D, Medeiros L, Christian P, Özel F, Akiyama K, Alberdi A, Alef W, Asada K, Azulay R, Ball D, Baloković M, Barrett J, Bintley D, Blackburn L, Boland W, Bower GC, Bremer M, Brinkerink CD, Brissenden R, Britzen S, Broguiere D, Bronzwaer T, Byun DY, Carlstrom JE, Chael A, Chan CK, Chatterjee S, Chatterjee K, Chen MT, Chen Y, Cho I, Conway JE, Cordes JM, Crew GB, Cui Y, Davelaar J, De Laurentis M, Deane R, Dempsey J, Desvignes G, Dexter J, Eatough RP, Falcke H, Fish VL, Fomalont E, Fraga-Encinas R, Friberg P, Fromm CM, Gammie CF, García R, Gentaz O, Goddi C, Gómez JL, Gu M, Gurwell M, Hada K, Hesper R, Ho LC, Ho P, Honma M, Huang CL, Huang L, Hughes DH, Inoue M, Issaoun S, James DJ, Jannuzi BT, Janssen M, Jiang W, Jimenez-Rosales A, Johnson MD, Jorstad S, Jung T, Karami M, Karuppusamy R, Kawashima T, Keating GK, Kettenis M, Kim JY, Kim J, Kim J, Kino M, Koay JY, Koch PM, Koyama S, Kramer M, Kramer C, Krichbaum TP, Kuo CY, Lauer TR, Lee SS, Li YR, Li Z, Lindqvist M, Lico R, Liu J, Liu K, Liuzzo E, Lo WP, Lobanov AP, Lonsdale C, Lu RS, Mao J, Markoff S, Marrone DP, Marscher AP, Martí-Vidal I, Matsushita S, Mizuno Y, Mizuno I, Moran JM, Moriyama K, Moscibrodzka M, Müller C, Musoke G, Mus Mejías A, Nagai H, Nagar NM, Narayan R, Narayanan G, Natarajan I, Neri R, Noutsos A, Okino H, Olivares H, Oyama T, Palumbo DCM, Park J, Patel N, Pen UL, Piétu V, Plambeck R, PopStefanija A, Prather B, Preciado-López JA, Ramakrishnan V, Rao R, Rawlings MG, Raymond AW, Ripperda B, Roelofs F, Rogers A, Ros E, Rose M, Roshanineshat A, Rottmann H, Roy AL, Ruszczyk C, Ryan BR, Rygl KLJ, Sánchez S, Sánchez-Arguelles D, Sasada M, Savolainen T, Schloerb FP, Schuster KF, Shao L, Shen Z, Small D, Sohn BW, SooHoo J, Tazaki F, Tilanus RPJ, Titus M, Torne P, Trent T, Traianou E, Trippe S, van Bemmel I, van Langevelde HJ, van Rossum DR, Wagner J, Wardle J, Ward-Thompson D, Weintroub J, Wex N, Wharton R, Wielgus M, Wong GN, Wu Q, Yoon D, Young A, Young K, Younsi Z, Yuan F, Yuan YF, Zhao SS; EHT Collaboration. Psaltis D, et al. Phys Rev Lett. 2020 Oct 2;125(14):141104. doi: 10.1103/PhysRevLett.125.141104. Phys Rev Lett. 2020. PMID: 33064506
The Theory of Genetic Vulnerability: a Roy model exemplar.
Hamilton RJ, Bowers BJ. Hamilton RJ, et al. Nurs Sci Q. 2007 Jul;20(3):254-64. doi: 10.1177/0894318407303127. Nurs Sci Q. 2007. PMID: 17595406
The theory of genetic vulnerability was developed and is composed of five concepts: (a) experiencing the family disease, (b) testing for a mutation, (c) fore-grounding inherited disease risk, (d) responding to knowledge of genetic vulnerability, and (e) altering or avoiding the f …
The theory of genetic vulnerability was developed and is composed of five concepts: (a) experiencing the family disease, (b) testing for a m …
80 questions for UK biological security.
Kemp L, Aldridge DC, Booy O, Bower H, Browne D, Burgmann M, Burt A, Cunningham AA, Dando M, Dick JTA, Dye C, Weiss Evans S, Gallardo B, Godfray HCJ, Goodfellow I, Gubbins S, Holt LA, Jones KE, Kandil H, Martin P, McCaughan M, McLeish C, Meany T, Millett K, ÓhÉigeartaigh SS, Patron NJ, Rhodes C, Roy HE, Shackelford G, Smith D, Spence N, Steiner H, Sundaram LS, Voeneky S, Walker JR, Watkins H, Whitby S, Wood J, Sutherland WJ. Kemp L, et al. PLoS One. 2021 Jan 6;16(1):e0241190. doi: 10.1371/journal.pone.0241190. eCollection 2021. PLoS One. 2021. PMID: 33406134 Free PMC article.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page